San Diego-based mostly Viking Therapeutics marked by itself as a serious competitor inside the weight loss drug industry in February just after revealing promising facts from a mid-phase demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when specified as being a weekly injection As well as in March